BioHealth News Archive
Washington DC’s Parker Health Secures $25 Million in Series A Funding
WASHINGTON–(BUSINESS WIRE)–Parker Health an innovative biotech company for electronic health records, hospital developer & management, and subscription-based health services, today announced that it has secured $25…
Read More
NIH 2023 SBIR and STTR Omnibus Notices of Funding Opportunity Have Been Published
Applicants are encouraged to review the 2023 SBIR and STTR Omnibus Notices of Funding Opportunity (NOFOs).These NOFOs encourage small businesses to submit grant applications…
Read More
University System of Maryland Momentum Fund Invests in Impruvon Health Alongside TCP Venture Capital, New Dominion Angels
Baltimore-based Digital Health Startup is Working to End Medication Errors and Streamline Workflows in Long-Term Care Settings Baltimore, Md. (July 11, 2023) – Impruvon Health (“Impruvon”),…
Read More
Maryland Tech Council Announces New Chair and Board
The Maryland Tech Council, the largest technology and life sciences trade association in the state, today welcomed a new chair and slate of technology…
Read More
NasaClip Unveils Groundbreaking Baltimore-Made Medical Device Transforming Nosebleed Treatment with Hands-Free Compression
New Device Provides an Effective, Hands-Free Solution to Stop Nosebleeds in Children and Adults Adult and Pediatric NasaClip Sizes Provide Easy-To-Use Options for Chronic…
Read More
BARDA seeks Consortium Management Firm to run new Rapid Response Partnership Vehicle
Responding faster and more effectively to future public health challenges and emergencies will require the development of a specific, rapid acquisition vehicle. To achieve…
Read More
BioHealth Innovation and Fhi 360 collaborate in developing a Life Science Tech Transfer and Commercialization Center in Sfax, Tunisia
The long-awaited grand opening of the Sfax University Simulation Center has finally arrived, marking a new era of innovative learning and development in Sfax,…
Read More
Applications to Compete in the 8th Annual BioHealth Capital Region Crab Trap are Now Being Accepted!
Now in its 8th year, the BioHealth Capital Region Crab Trap continues to grow, attracting applicants from around the region, country, and internationally. The competition…
Read More
MaxCyte and Vittoria Biotherapeutics Sign Strategic Platform License to Advance Next Generation Cellular Therapies
MaxCyte’s Flow Electroporation® technology and ExPERT™ platform will support Vittoria’s Senza5™ technology to enhance efficacy and improve clinical utility of T-cell therapies. ROCKVILLE, Md.…
Read More
BioFactura and CuraTeQ Sign Exclusive License for BFI-751—A Biosimilar to Stelara
FREDERICK, MARYLAND, July10, 2021: BioFactura, Inc. today announced that CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has entered into…
Read More
Building Better Medicine, and Transformative Partnerships: Insights from Joy Polefrone, Ph.D. on BioTalk
Ever wondered how public-private partnerships can make a significant difference in the field of life sciences? Curious about the goals, expected impacts, and timeline…
Read More
MarylandToday: $4.4M NIH Award Supports UMD Research on Enzymes to Combat Pneumonia
The National Institutes for Health (NIH) has awarded $4.4 million to a University of Maryland researcher and a colleague to develop both a novel…
Read More
Children’s National Hospital, Virginia Tech unite to advance AI for pediatric health
Expectations are high for combining human and artificial intelligence against health problems. “Start by determining the problem you desire to solve, then decide on…
Read More
Theradaptive Awarded Manufacturing Assistance Grant by the Maryland Stem Cell Research Fund
FREDERICK, Md., July 6, 2023 /PRNewswire/ -- Today, Theradaptive, a biopharmaceutical firm pioneering advancements in targeted regenerative therapeutics, has been awarded the Manufacturing Assistance Program grant by the…
Read More
MaxCyte Signs Strategic Platform License with Lyell Immunopharma
Lyell Immunopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform in its T cell product candidates targeting solid tumors. ROCKVILLE, Md., July 06,…
Read More